$1.47
-0.08-5.16%
At close: -
$1.44
-0.03-2.04%
After Hours: Jan 31, 7:48 PM EDT
Predictive Oncology reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Predictive Oncology using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2023-03-21 | $-2.00 | $-1.20 | -66.7 % |
Q4 | 2022-03-31 | $-2.60 | $-0.40 | -550.0 % |
Q3 | 2021-11-10 | $-1.60 | $-1.00 | -60.0 % |
Q2 | 2021-08-11 | $-1.00 | $-1.40 | 28.6 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q2 | 2022-08-11 | $371.59K | $2.00M | -81.4 % |
Q3 | 2021-11-10 | $313.66K | $1.20M | -73.9 % |
Q2 | 2021-08-11 | $350.21K | $600.00K | -41.6 % |
Q1 | 2021-05-12 | $280.32K | $400.00M | -99.9 % |
Predictive Oncology (POAI) is scheduled to report earnings on March 27, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.36, which missed the estimate of $0.00.
The Actual Revenue was $345.7K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.